Agilon Health AGL Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $5.82B-2.8% | $5.93B-2.1% | $5.89B+5.2% | $5.9B+11.8% | $5.99B+23.1% | ||
| $226.81M-12.2% | $238.54M-11.3% | $238.19M-13.0% | $245.12M-13.3% | $258.45M-11.6% | ||
| $28.51M+11.8% | $28.59M+16.9% | $28.12M+23.9% | $26.91M+30.9% | $25.5M+34.7% | ||
| —— | $36.09M+903% | $27.96M+937% | $19.84M+1,003% | $11.72M+1,203% | ||
| $6.26B-0.6% | $6.4B+0.7% | $6.26B+5.4% | $6.28B+13.5% | $6.3B+23.3% | ||
| -$437.13M-42.4% | -$463.24M-58.6% | -$377.51M-8.4% | -$379.75M-49.4% | -$307.06M-28.1% | ||
| -7.5%-2.4pp | -7.8%-3.0pp | -6.4%-0.2pp | -6.4%-1.6pp | -5.1%-0.2pp | ||
| $6.94M+8.3% | $6.64M+7.5% | $6.5M-1.5% | $6.28M-4.7% | $6.41M-0.6% | ||
| $74.38M+96.5% | $67.62M+96.1% | $34.28M+0.1% | $40.9M+73.3% | $37.86M+46.5% | ||
| -$2.77M— | -$1.84M— | —— | —— | —— | ||
| -$372.46M-46.9% | -$404.1M-62.4% | -$321.21M-3.3% | -$327.7M-52.5% | -$253.63M-27.1% | ||
| $1.08M-39.2% | $1.25M-13.8% | $1.68M+4,418% | $1.43M-19.1% | $1.78M-26.4% | ||
| -$354.54M-46.5% | -$391.35M-50.4% | -$308.26M+19.9% | -$315.66M-5.7% | -$241.98M+15.0% | ||
| -6.1%-2.1pp | -6.6%-2.3pp | -5.2%+1.6pp | -5.3%+0.3pp | -4%+1.8pp | ||
| —— | —— | —— | —— | -$0.57-10.7% | ||
| $1.18+100% | $0.87+100% | -$8,122,999.16+87.5% | -$9,305,999.16+87.3% | -$9,305,999.16+87.4% | ||
| $1.96+1,682% | -$0.25+59.0% | -$0.05+93.4% | -$0.07+86.8% | $0.11+122% | ||
| $1.97+1,691% | -$0.25+59.0% | -$0.05+93.4% | -$0.07+86.8% | $0.11+122% | ||
| 1.3B+0.7% | 1.3B-23.4% | 1.3B-23.5% | 1.3B-23.4% | 1.3B-23.5% | ||
| 1.3B+0.7% | 1.3B-23.4% | 1.3B-23.5% | 1.3B-23.4% | 1.3B-23.5% | ||
| $0.82+212% | -$1.09-78.7% | -$0.89-17.1% | -$0.91-71.7% | -$0.73-46.0% | ||
| $0.82+212% | -$1.09-78.7% | -$0.89-17.1% | -$0.91-71.7% | -$0.73-46.0% | ||
| $19M+35.7% | $14M+260% | $14M+125% | $14M+125% | $14M— | ||
| —— | $0+100% | -$265.25K+95.4% | -$530.5K+95.0% | -$795.75K+94.8% | ||
| —— | —— | —— | —— | —— | ||
| $5.82B-2.8% | $5.93B-2.1% | $5.89B+5.2% | $5.9B+11.8% | $5.99B+23.1% | ||
| -$437.13M-42.4% | -$463.24M-58.6% | -$377.51M-8.4% | -$379.75M-49.4% | -$307.06M-28.1% | ||
| -$408.62M-45.1% | -$434.64M-62.4% | -$349.39M-7.4% | -$352.84M-52.1% | -$281.57M-29.2% | ||
| -$408.62M-45.1% | -$434.64M-62.4% | -$349.39M-7.4% | -$352.84M-52.1% | -$281.57M-29.2% | ||
| -7%-2.3pp | -7.3%-2.9pp | -5.9%-0.1pp | -6%-1.6pp | -4.7%-0.2pp | ||
| -$437.13M-42.4% | -$463.24M-58.6% | -$377.51M-8.4% | -$379.75M-49.4% | -$307.06M-28.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Agilon Health's revenue?
- Agilon Health (AGL) generated $5.8B in revenue over the trailing twelve months, down 2.8% year over year.
- Is Agilon Health profitable?
- Agilon Health is not currently profitable: it reported a net loss of $354.5M over the trailing twelve months, a -6.1% net margin.
- What is Agilon Health's earnings per share?
- Agilon Health's diluted EPS over the trailing twelve months is $1.96.
- Where does Agilon Health's income statement data come from?
- Every line is extracted from Agilon Health's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
